DK236477A - Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf - Google Patents

Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf

Info

Publication number
DK236477A
DK236477A DK236477A DK236477A DK236477A DK 236477 A DK236477 A DK 236477A DK 236477 A DK236477 A DK 236477A DK 236477 A DK236477 A DK 236477A DK 236477 A DK236477 A DK 236477A
Authority
DK
Denmark
Prior art keywords
aciloxy
aalte
cyan2
eraf
pyridines
Prior art date
Application number
DK236477A
Other languages
English (en)
Inventor
J J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK236477A publication Critical patent/DK236477A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK236477A 1976-06-15 1977-05-27 Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf DK236477A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/696,236 US4053605A (en) 1976-06-15 1976-06-15 Esterified-2(3-lower-alkyl-amino-propoxy)-3-cyano-pyridines and derivatives

Publications (1)

Publication Number Publication Date
DK236477A true DK236477A (da) 1977-12-16

Family

ID=24796248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK236477A DK236477A (da) 1976-06-15 1977-05-27 Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf

Country Status (9)

Country Link
US (3) US4053605A (da)
JP (1) JPS52153972A (da)
CH (1) CH632499A5 (da)
DE (1) DE2726754A1 (da)
DK (1) DK236477A (da)
FR (1) FR2355007A1 (da)
GB (1) GB1545708A (da)
NL (1) NL7705883A (da)
SE (1) SE428685B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
JPS54106476A (en) * 1978-01-04 1979-08-21 Merck & Co Inc Multiisubstituted 22*33lower alkylaminoo22 r100propoxy*pyridine
US4279913A (en) * 1978-01-04 1981-07-21 Merck & Co., Inc. Polysubstituted-2-(3-loweralkylamino-2-R1 O-propoxy)pyridines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
US4393212A (en) * 1979-01-29 1983-07-12 Merck & Co., Inc. Certain nicotinic acid esters and corresponding nicotinonitriles
DE2943774A1 (de) * 1979-10-26 1981-05-14 1000 Berlin Schering Ag Berlin Und Bergkamen Substituierte pyridine, verfahren zu ihrer herstellung und ihre verwendung
US4436740A (en) * 1982-07-26 1984-03-13 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines
US4550117A (en) * 1982-07-26 1985-10-29 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines, derivatives thereof, having anti-hypertensive activity
ES2908318T3 (es) 2013-12-02 2022-04-28 Univ Queensland Separador.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946009A (en) * 1972-05-05 1976-03-23 Merck Sharp & Dohme (I.A.) Corporation 2-(3-Substituted amino-2-hydroxypropoxy)-3-substituted pyrazines
US4001327A (en) * 1972-07-05 1977-01-04 The Regents Of The University Of Michigan Novel quaternary salts and method
JPS5641637B2 (da) * 1973-11-26 1981-09-29
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
US4000282A (en) * 1974-12-16 1976-12-28 Merck & Co., Inc. 2-(3-tert. butyl or isopropylamino-2-hydroxypropoxy)-3-cyanopyridines
US4060601A (en) * 1976-06-15 1977-11-29 Merck & Co., Inc. Certain lower-alkyl amino-2'-hydroxy-propoxy pyridines

Also Published As

Publication number Publication date
US4119630A (en) 1978-10-10
SE7706182L (sv) 1977-12-16
FR2355007B1 (da) 1980-04-18
US4119721A (en) 1978-10-10
FR2355007A1 (fr) 1978-01-13
GB1545708A (en) 1979-05-10
JPS52153972A (en) 1977-12-21
US4053605A (en) 1977-10-11
SE428685B (sv) 1983-07-18
CH632499A5 (de) 1982-10-15
NL7705883A (nl) 1977-12-19
DE2726754A1 (de) 1977-12-29

Similar Documents

Publication Publication Date Title
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK377A (da) Fremgangsmade til fremstilling af n-phosphonomethyl-glycin
DK352176A (da) Fremgangsmade til femstilling af acyl-3-oxo-1,2-benzisothiazoliner eller acylsacchariner
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK236477A (da) Fremgangsmade til fremstilling af 3-cyan2-(3-alkylamino-2-aciloxy-propoxy)-pyridiner eller farmaceutisk acceptable aalte :eraf
DK577977A (da) Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK587077A (da) Fremgangsmaade til fremstilling af estere
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK31377A (da) Fremgangsmade til fremstilling af et antihypertensivt middel
DK152377A (da) Fremgangsmade til fremstilling af alkylthiomethylphenoler
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK216977A (da) Fremgangsmade til fremstilling af imidazobenzoxaziner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK73277A (da) Fremgangsmaade til fremstilling af sulfonylbenzimidazoler
DK407077A (da) Fremgangsmaade til fremstilling af indolerinderivater
DK538977A (da) Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester
DK31277A (da) Fremgangsmade til fremstilling af et antihypertensivt middel
DK31177A (da) Fremgangsmade til fremstilling af et antihypertensivt middel
DK346977A (da) Fremgangsmade til femstilling af 2,3-alkylenbis-(oxy)-benzamider eller derivater deraf
DK338677A (da) Frefmgangsmade til fremstilling af 3-alkoxycyproheptadiner